IBOG.F Stock Overview

A life sciences company, develops, acquires, and operates addiction treatment clinics in Canada. More details

IBOG.F fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Does not have a meaningful market cap ($9M)

Highly volatile share price over the past 3 months compared to the US market

Has less than 1 year of cash runway

Does not have meaningful revenue (CA$2M)

Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

Universal Ibogaine Inc. Competitors

Inspire Veterinary Partners

NasdaqCM:IVP

US$8.0m

Ethema Health

OTCPK:GRST

US$2.3m

SunLink Health Systems

NYSEAM:SSY

US$6.1m

Regional Health Properties

OTCPK:RHEP

US$4.8m

Price History & Performance

Summary of share price highs, lows and changes for Universal Ibogaine
Historical stock prices
Current Share Price	CA$0.021
52 Week High	CA$0.10
52 Week Low	CA$0.0013
Beta	6.92
1 Month Change	-67.69%
3 Month Change	5.00%
1 Year Change	89.19%
3 Year Change	-61.33%
5 Year Change	n/a
Change since IPO	-72.26%

Recent updates

Shareholder Returns

	IBOG.F	US Healthcare	US Market
7D	23.5%	-0.9%	2.8%
1Y	89.2%	-10.0%	9.3%

Return vs Industry: IBOG.F exceeded the US Healthcare industry which returned -10% over the past year.

Return vs Market: IBOG.F exceeded the US Market which returned 9.3% over the past year.

Price Volatility

Is IBOG.F's price volatile compared to industry and market?
IBOG.F volatility
IBOG.F Average Weekly Movement	44.8%
Healthcare Industry Average Movement	7.6%
Market Average Movement	7.9%
10% most volatile stocks in US Market	16.3%
10% least volatile stocks in US Market	4.2%

Stable Share Price: IBOG.F's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine IBOG.F's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
n/a	n/a	Nick Karos	universalibogaine.com

Universal Ibogaine Inc., a life sciences company, develops, acquires, and operates addiction treatment clinics in Canada. The company also undertakes planned clinical trial for research into the use of ibogaine for addiction treatment. Universal Ibogaine Inc. is headquartered in Calgary, Canada.

Universal Ibogaine Inc. Fundamentals Summary

How do Universal Ibogaine's earnings and revenue compare to its market cap?
IBOG.F fundamental statistics
Market cap	US$6.70m
Earnings (TTM)	-US$1.65m
Revenue (TTM)	US$1.37m

4.9x

P/S Ratio

-4.1x

P/E Ratio

Is IBOG.F overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
IBOG.F income statement (TTM)
Revenue	CA$1.90m
Cost of Revenue	CA$1.71m
Gross Profit	CA$189.40k
Other Expenses	CA$2.46m
Earnings	-CA$2.27m

Last Reported Earnings

Jan 31, 2025

Next Earnings Date

n/a

Earnings per share (EPS)	-0.0074
Gross Margin	9.99%
Net Profit Margin	-119.86%
Debt/Equity Ratio	740.6%

How did IBOG.F perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/05/05 08:22
End of Day Share Price	2025/05/02 00:00
Earnings	2025/01/31
Annual Earnings	2024/07/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Universal Ibogaine Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.